Page 12 - Anna Maddison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

    OTTAWA, Ont. (CTV Network) — OTTAWA — Canadians will “shortly” receive federal guidance around what they can, and can’t do safely after their first and second COVID-19 shots, according to Health Minister Patty Hajdu. Facing questions about why Canada has yet to offer any formal guidance to people who have been vaccinated about what degree of risk they have in certain circumstances in the way the United States has, Hajdu said it’s in the works. “We are working with provinces and territories to understand their own epidemiology… It’s the percentage of Canadians that a...

updated: Apr 09 2021, 11:37 ist By James Paton, Tim Loh and Todd Gillespie, Growing worries that AstraZeneca Plc’s Covid-19 vaccine causes rare blood clots could hinder immunization campaigns across the world, from London to Seoul. Reviews by UK and European Union regulators finding potential links to the unusual side effects are another blow for the shot, a cheaper and easier-to-deploy product that many nations are counting on in a bid to end the pandemic. Safety concerns could shake confidence in the injection, even though regulators reiterated that its benefits outweigh the risks. Many r...

LONDON (BLOOMBERG) - Growing worries that AstraZeneca's Covid-19 vaccine causes rare blood clots could hinder immunisation campaigns across the world, from London to Seoul. Safety concerns following increasing reports of blood clots in people who received the inoculation could shake confidence in it, even though regulators have agreed that the benefits outweigh the risks. Although many regions are turning their attention to vaccines from Johnson & Johnson and developers in China, Russia and elsewhere, they're in a difficult position with demand for doses far outstripping supply. "Better Astra...

Worries over AstraZeneca COVID-19 vaccine side effects complicate bid to vaccinate the world SECTIONS Worries over AstraZeneca COVID-19 vaccine side effects complicate bid to vaccinate the worldBy James Paton, Tim Loh and Todd Gillespie, Bloomberg Last Updated: Apr 08, 2021, 03:34 PM IST Share Synopsis Reviews by U.K. and European Union regulators finding potential links to the unusual side effects are another blow for the shot, a cheaper and easier-to-deploy product that many nations are counting on in a bid to end the pandemic. Reuters Growing worries that AstraZeneca Plc’s Covid-19 vacci...

SINGAPORE (BLOOMBERG, REUTERS) - European and British drug regulators have found possible links between rare blood clots and the AstraZeneca Covid-19 vaccine. The European Medicines Agency and UK's the Medicines and Healthcare Products Regulatory Agency said they found rare cases of blood clots among some adult vaccine recipients, although they said the vaccine's advantages still outweighed the risks. Here are some countries' guidance on the usage of the vaccine. Australia Australia, which relies heavily on the AstraZeneca shots to vaccinate its near 26 million population, will continue with ...